Position in ERAS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,335,600
+$2,834,400 QoQ
Shares Held
455,000
+33.8% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
6.12%
of 13F equity value
Holder Rank
#65
of 257 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KVP Capital Advisors, LP holds $128,082,843 across 32 Biotechnology names. ERAS ranks #3 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
42,900 | $14,362,491 | |
| 2 | WHWK |
Whitehawk Therapeutics, Inc.
|
2,165,997 | $9,920,266 | |
| 3 | ERAS |
Erasca, Inc.
This page
|
455,000 | $8,335,600 | |
| 4 | TRVI |
Trevi Therapeutics, Inc.
|
414,000 | $7,721,100 | |
| 5 | STRO |
Sutro Biopharma, Inc.
|
226,575 | $7,522,290 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
230,264 | $7,198,052 | |
| 7 | MBX |
MBX Biosciences, Inc.
|
121,524 | $6,708,124 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
53,000 | $6,496,740 |
All Filings in ERAS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,335,600 | 455,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,501,200 | 340,000 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||